Method for treating established spontaneous auto-immune diseases in mammals
US7041289B1 · kind B1 · utility
11Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 1997 |
| Grant date | May 9, 2006 |
| Priority date | — |
| Expiry date | Jul 17, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating spontaneous and ongoing auto-immune diseases in mammals, comprising administering to a mammal, in need of such a treatment, a therapeutically effective amount of one or more non mitogenic anti-CD3 active principles to achieve permanent disease remission through the induction of antigen-specific unresponsiveness, i.e. immune tolerance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.